---
authors:
- Slawson, David C
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36920801/
file_path: 2023/03/tocilizumab-beneficial-for-adults-with-persistent-polymyalgi.md
issue: '3'
keywords:
- Humans
- Polymyalgia Rheumatica
- Giant Cell Arteritis
- Adult
- Steroids
- Antibodies, Monoclonal, Humanized
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Adult
- Polymyalgia Rheumatica
- Giant Cell Arteritis
- Antibodies, Monoclonal, Humanized
- Steroids
original_format: PubMed
pages: 317-318
patient_population: Adults
peer_reviewed: true
pmid: '36920801'
processed_date: '2025-07-30'
publication_date: '2023-03-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Tocilizumab Beneficial for Adults With Persistent Polymyalgia Rheumatica Symptoms
  Who Receive Steroid Therapy.
topics:
- Family Medicine
volume: '107'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36920801'
  title: Tocilizumab Beneficial for Adults With Persistent Polymyalgia Rheumatica
    Symptoms Who Receive Steroid Therapy.
  authors:
  - last_name: Slawson
    fore_name: David C
    initials: DC
    affiliation: Atrium Health, Charlotte, NC.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '107'
    issue: '3'
  publication_info:
    year: '2023'
    month: '03'
    full_date: '2023-03-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Adult
    major_topic: false
  - descriptor: Polymyalgia Rheumatica
    major_topic: true
    qualifiers:
    - qualifier: diagnosis
      major_topic: false
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Giant Cell Arteritis
    major_topic: true
    qualifiers:
    - qualifier: diagnosis
      major_topic: false
  - descriptor: Antibodies, Monoclonal, Humanized
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Steroids
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '36920801'
  title: Tocilizumab Beneficial for Adults With Persistent Polymyalgia Rheumatica
    Symptoms Who Receive Steroid Therapy.
  authors:
  - name: Slawson DC
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Mar
- pmid: '23615930'
  title: '[Tocilizumab for treatment of large vessel vasculitis and polymyalgia rheumatica].'
  authors:
  - name: Henes JC
    authtype: Author
    clusterid: ''
  - name: Xenitidis T
    authtype: Author
    clusterid: ''
  source: Z Rheumatol
  pubdate: 2013 Jun
- pmid: '34939291'
  title: Whipple disease mimicking polymyalgia rheumatica with initial response to
    tocilizumab.
  authors:
  - name: Meudec L
    authtype: Author
    clusterid: ''
  - name: Jelin G
    authtype: Author
    clusterid: ''
  - name: Goossens J
    authtype: Author
    clusterid: ''
  - name: Forien M
    authtype: Author
    clusterid: ''
  - name: Jacquier H
    authtype: Author
    clusterid: ''
  - name: Dieud√© P
    authtype: Author
    clusterid: ''
  - name: Ottaviani S
    authtype: Author
    clusterid: ''
  source: Intern Med J
  pubdate: 2021 Dec
- pmid: '36125471'
  title: 'Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia
    Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.'
  authors:
  - name: Devauchelle-Pensec V
    authtype: Author
    clusterid: ''
  - name: Carvajal-Alegria G
    authtype: Author
    clusterid: ''
  - name: Dernis E
    authtype: Author
    clusterid: ''
  - name: Richez C
    authtype: Author
    clusterid: ''
  - name: Truchetet ME
    authtype: Author
    clusterid: ''
  - name: Wendling D
    authtype: Author
    clusterid: ''
  - name: Toussirot E
    authtype: Author
    clusterid: ''
  - name: Perdriger A
    authtype: Author
    clusterid: ''
  - name: Gottenberg JE
    authtype: Author
    clusterid: ''
  - name: Felten R
    authtype: Author
    clusterid: ''
  - name: Fautrel BJ
    authtype: Author
    clusterid: ''
  - name: Chiche L
    authtype: Author
    clusterid: ''
  - name: Hilliquin P
    authtype: Author
    clusterid: ''
  - name: Le Henaff C
    authtype: Author
    clusterid: ''
  - name: Dervieux B
    authtype: Author
    clusterid: ''
  - name: Direz G
    authtype: Author
    clusterid: ''
  - name: Chary-Valckenaere I
    authtype: Author
    clusterid: ''
  - name: Cornec D
    authtype: Author
    clusterid: ''
  - name: Guellec D
    authtype: Author
    clusterid: ''
  - name: Marhadour T
    authtype: Author
    clusterid: ''
  - name: Nowak E
    authtype: Author
    clusterid: ''
  - name: Saraux A
    authtype: Author
    clusterid: ''
  source: JAMA
  pubdate: 2022 Sep 20
- pmid: '32898757'
  title: Response to a letter to the editor entitled "Is tocilizumab as efficient
    as steroids early in polymyalgia rheumatica?".
  authors:
  - name: Akiyama M
    authtype: Author
    clusterid: ''
  - name: Kaneko Y
    authtype: Author
    clusterid: ''
  - name: Takeuchi T
    authtype: Author
    clusterid: ''
  source: Semin Arthritis Rheum
  pubdate: 2020 Oct
---

# Tocilizumab Beneficial for Adults With Persistent Polymyalgia Rheumatica Symptoms Who Receive Steroid Therapy.

**Authors:** Slawson, David C

**Published in:** American family physician | Vol. 107, No. 3 | 2023-03-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36920801/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Adult, Polymyalgia Rheumatica, Giant Cell Arteritis, Antibodies, Monoclonal, Humanized, Steroids

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36920801/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
